Institutions Received $3 Million Grant for HIV Research

Weill Cornell Medicine and Rutgers Health established a new center to study the impact of HIV on brain health.

Updated on Sept. 29, 2026 in Alzheimer’s

Isometric editorial illustration of a lab-grown brain organoid in a circular vessel, representing scientific research into HIV and neurology. — Weill Cornell Medicine and Rutgers Health received a $3 million federal grant to establish a new center for studying HIV-related brain injury. AI Illustration. Upload story photo >

Live Poll

Should federal grants prioritize funding research centers to identify biological markers for complex diseases?

Weill Cornell Medicine and Rutgers Health have secured a $3 million federal grant to launch the New York-New Jersey Center for Actionable NeuroHIV Biomarkers. The four-year award aims to enhance research capacity regarding how the virus persists in brain reservoirs.

Why it matters

Medical experts lack effective therapies to prevent or mitigate HIV-related brain injury, which can cause significant cognitive, behavioral, and movement problems. This project seeks to identify biological markers that could inform future treatments.

The National Institute of Mental Health awarded a $3 million grant to support the center over a four-year period. This funding is dedicated exclusively to research capacity, shared tools, and pilot grants for junior investigators.

The players

Weill Cornell Medicine

This is a medical school and research institution based in New York that partners with major clinical and scientific organizations.

Rutgers Health

Based in New Jersey, this academic health center integrates clinical care, research, and education across multiple health disciplines.

National Institute of Mental Health

This federal agency is the lead organization for research on mental disorders and neurological conditions within the United States.

The details

The new center provides molecular and computational resources to study the central nervous system, utilizing human-tissue culture techniques like organoids to observe how HIV affects brain cells. These shared tools are intended to facilitate interdisciplinary investigations into ongoing brain injury.

The federal grant provides funding for a four-year period.

Health Landscape

This initiative represents a significant investment in the National Institute of Mental Health's existing HIV research portfolio. It marks a shift toward specialized, regional research centers designed to bridge the gap between basic laboratory science and clinical diagnostics.

While this grant focuses on research infrastructure rather than immediate patient treatments, its success could lead to future clinical diagnostic tools for those living with HIV. Patients may eventually benefit from improved methods for detecting and monitoring HIV-related neurological changes.

The takeaway

Ongoing research into how HIV persists in brain tissue is essential for developing long-term neurological care strategies. Supporting junior researchers and shared laboratory infrastructure helps create a sustainable pipeline for future medical breakthroughs.